middle.news
Neuren Expands NNZ-2591 Pipeline with SYNGAP1 Disorder After Promising Lab Results
9:23am on Friday 8th of August, 2025 AEST
•
Healthcare
Read Story
Neuren Expands NNZ-2591 Pipeline with SYNGAP1 Disorder After Promising Lab Results
9:23am on Friday 8th of August, 2025 AEST
Key Points
SYNGAP1-related disorder (SRD) added to NNZ-2591 pipeline
Positive reversal of neuronal dysfunction in pre-clinical SRD model
SRD affects 1 in 16,000 with no current approved therapies
Neuren preparing Phase 3 trial for Phelan-McDermid syndrome
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NEU
OPEN ARTICLE